1. Home
  2. MYO vs PSTV Comparison

MYO vs PSTV Comparison

Compare MYO & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myomo Inc.

MYO

Myomo Inc.

HOLD

Current Price

$1.46

Market Cap

33.3M

Sector

Health Care

ML Signal

HOLD

Logo PLUS THERAPEUTICS Inc.

PSTV

PLUS THERAPEUTICS Inc.

HOLD

Current Price

$4.57

Market Cap

34.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYO
PSTV
Founded
2004
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.3M
34.5M
IPO Year
2017
2016

Fundamental Metrics

Financial Performance
Metric
MYO
PSTV
Price
$1.46
$4.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$7.67
$55.00
AVG Volume (30 Days)
1.1M
131.9K
Earning Date
05-08-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
87.61
EPS
N/A
N/A
Revenue
$1,000,000,000.00
$5,213,000.00
Revenue This Year
$9.10
$13.20
Revenue Next Year
$13.59
$261.48
P/E Ratio
N/A
N/A
Revenue Growth
40814.79
N/A
52 Week Low
$0.61
$0.13
52 Week High
$2.83
$8.00

Technical Indicators

Market Signals
Indicator
MYO
PSTV
Relative Strength Index (RSI) 64.05 35.91
Support Level $0.76 $0.37
Resistance Level N/A $6.65
Average True Range (ATR) 0.18 0.46
MACD 0.02 -0.17
Stochastic Oscillator 80.65 5.53

Price Performance

Historical Comparison
MYO
PSTV

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, commercializing and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

Share on Social Networks: